Modeling stress-induced responses: plasticity in continuous state space and gradual clonal evolution
暂无分享,去创建一个
[1] Joel s. Brown,et al. Integrating eco‐evolutionary dynamics into matrix population models for structured populations: Discrete and continuous frameworks , 2023, Methods in Ecology and Evolution.
[2] W. Shi,et al. Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. , 2022, Cell reports.
[3] Joel s. Brown,et al. A life history model of the ecological and evolutionary dynamics of polyaneuploid cancer cells , 2022, Scientific Reports.
[4] Joel s. Brown,et al. Stochastic models of Mendelian and reverse transcriptional inheritance in state-structured cancer populations , 2022, Scientific Reports.
[5] Joel s. Brown,et al. Coupled Source-Sink Habitats Produce Spatial and Temporal Variation of Cancer Cell Molecular Properties as an Alternative to Branched Clonal Evolution and Stem Cell Paradigms , 2021, Frontiers in Ecology and Evolution.
[6] K. Pienta,et al. Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells , 2021, Proceedings of the National Academy of Sciences.
[7] K. Pienta,et al. Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy. , 2020, Seminars in cancer biology.
[8] S. Sivaloganathan,et al. A mathematical study of the impact of cell plasticity on tumour control probability. , 2020, Mathematical biosciences and engineering : MBE.
[9] J. Clairambault,et al. Cell plasticity in cancer cell populations , 2020, F1000Research.
[10] A. Hillmer,et al. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer , 2020, Cells.
[11] Joel s. Brown,et al. Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer , 2020, Molecular Cancer Research.
[12] Joel s. Brown,et al. Poly‐aneuploid cancer cells promote evolvability, generating lethal cancer , 2020, Evolutionary applications.
[13] Li You,et al. Towards Multidrug Adaptive Therapy , 2020, Cancer Research.
[14] G. F. Calvo,et al. Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma , 2020, Cell Death & Disease.
[15] H. Caswell,et al. A matrix model for density-dependent selection in stage-classified populations, with application to pesticide resistance in Tribolium , 2020, Ecological Modelling.
[16] A. Eggermont,et al. An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells , 2019, Nature Communications.
[17] Neil Vasan,et al. A view on drug resistance in cancer , 2019, Nature.
[18] Robert A. Gatenby,et al. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma , 2019, EBioMedicine.
[19] C. Lim,et al. Epithelial-mesenchymal plasticity-engaging stemness in an interplay of phenotypes. , 2019, Stem cell investigation.
[20] Ke-Chih Lin,et al. Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance , 2019, The Prostate.
[21] Qingsong Liu,et al. Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance , 2019, Nature Communications.
[22] Hal Caswell,et al. Sensitivity Analysis: Matrix Methods in Demography and Ecology , 2019, Demographic Research Monographs.
[23] K. Shokat,et al. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition , 2019, Science Signaling.
[24] R. Albert,et al. Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition , 2018, Physical biology.
[25] P. Kočovský,et al. A spatially discrete, integral projection model and its application to invasive carp , 2018, Ecological Modelling.
[26] J. Tabernero,et al. A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy , 2018, Nature.
[27] F. Peale,et al. A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition , 2018, Nature.
[28] J. Shih,et al. Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI , 2018, Oncogene.
[29] K. Flaherty,et al. Toward Minimal Residual Disease-Directed Therapy in Melanoma , 2018, Cell.
[30] E. Furth,et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.
[31] T. Graeber,et al. Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. , 2018, Cancer cell.
[32] Robert A Gatenby,et al. Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies , 2017, bioRxiv.
[33] P. Parren,et al. Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors , 2018, Nature Medicine.
[34] N. McDowell,et al. Incorporating variability in simulations of seasonally forced phenology using integral projection models , 2017, Ecology and evolution.
[35] William F Basener,et al. The fundamental theorem of natural selection with mutations , 2017, Journal of mathematical biology.
[36] R. Young,et al. Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression. , 2017, Cancer discovery.
[37] P. Giresi,et al. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. , 2017, Cancer cell.
[38] Jill P. Mesirov,et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway , 2017, Nature.
[39] Stuart L. Schreiber,et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition , 2017, Nature.
[40] R. Fisher,et al. Persistent bacterial infections and persister cells , 2017, Nature Reviews Microbiology.
[41] Sydney M. Shaffer,et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.
[42] S. Rosenberg,et al. Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance. , 2017, Annual review of cancer biology.
[43] Shawn M. Gillespie,et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.
[44] Sendurai A Mani,et al. Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia , 2016, Scientific Reports.
[45] B. Young,et al. Using integral projection models to compare population dynamics of four closely related species , 2016, Population Ecology.
[46] A. Graham,et al. Opportunities and challenges of Integral Projection Models for modelling host–parasite dynamics , 2015, Journal of Animal Ecology.
[47] N. Vasilevsky,et al. Author response: Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations , 2015 .
[48] J. Stenvang,et al. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance , 2015, Molecular oncology.
[49] R. Gillies,et al. Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges” , 2015, International journal of cancer.
[50] Sarah A Heerboth,et al. Drug Resistance in Cancer: An Overview , 2014, Cancers.
[51] Cory Merow,et al. Advancing population ecology with integral projection models: a practical guide , 2014 .
[52] Dylan Z Childs,et al. Building integral projection models: a user's guide , 2014, The Journal of animal ecology.
[53] Tim Coulson,et al. Integral projections models, their construction and use in posing hypotheses in ecology , 2012 .
[54] Stephen P Ellner,et al. Avoiding unintentional eviction from integral projection models. , 2012, Ecology.
[55] H. Caswell. Matrix models and sensitivity analysis of populations classified by age and stage: a vec-permutation matrix approach , 2012, Theoretical Ecology.
[56] T. Golub,et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.
[57] Johan Ehrlén,et al. Interdependent effects of habitat quality and climate on population growth of an endangered plant , 2011 .
[58] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[59] Shripad Tuljapurkar,et al. Using evolutionary demography to link life history theory, quantitative genetics and population ecology , 2010, The Journal of animal ecology.
[60] Stephen P Ellner,et al. Coexistence of perennial plants: an embarrassment of niches. , 2010, Ecology letters.
[61] Knut Rydgren,et al. Investigating the interaction between ungulate grazing and resource effects on Vaccinium myrtillus populations with integral projection models , 2010, Oecologia.
[62] Jennifer L. Williams,et al. Testing hypotheses for exotic plant success: parallel experiments in the native and introduced ranges. , 2010, Ecology.
[63] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[64] R. Lande,et al. Adaptation, Plasticity, and Extinction in a Changing Environment: Towards a Predictive Theory , 2010, PLoS biology.
[65] Jennifer L. Williams. Flowering Life‐History Strategies Differ between the Native and Introduced Ranges of a Monocarpic Perennial , 2009, The American Naturalist.
[66] Johan Ehrlén,et al. Linking environmental variation to population dynamics of a forest herb , 2009 .
[67] M. Yamada,et al. DinB Upregulation Is the Sole Role of the SOS Response in Stress-Induced Mutagenesis in Escherichia coli , 2009, Genetics.
[68] James O. Eckberg,et al. Impacts of insect herbivory on cactus population dynamics: experimental demography across an environmental gradient , 2009 .
[69] Mark Rees,et al. Life‐History Variation in Contrasting Habitats: Flowering Decisions in a Clonal Perennial Herb (Veratrum album) , 2008, The American Naturalist.
[70] S. Lovett. Replication arrest-stimulated recombination: Dependence on the RecA paralog, RadA/Sms and translesion polymerase, DinB. , 2006, DNA repair.
[71] Yi Lu,et al. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. , 2006, Cancer research.
[72] A. Badyaev. Stress-induced variation in evolution: from behavioural plasticity to genetic assimilation , 2005, Proceedings of the Royal Society B: Biological Sciences.
[73] M. Rees,et al. DEMOGRAPHIC AND EVOLUTIONARY IMPACTS OF NATIVE AND INVASIVE INSECT HERBIVORES ON CIRSIUM CANESCENS , 2005 .
[74] J. Petrosino,et al. Adaptive Amplification and Point Mutation Are Independent Mechanisms: Evidence for Various Stress-Inducible Mutation Mechanisms , 2004, PLoS biology.
[75] S. Rosenberg,et al. General stress response regulator RpoS in adaptive mutation and amplification in Escherichia coli. , 2004, Genetics.
[76] J. C. Layton,et al. Error‐prone DNA polymerase IV is controlled by the stress‐response sigma factor, RpoS, in Escherichia coli , 2003, Molecular microbiology.
[77] Mark Rees,et al. Evolutionary demography of monocarpic perennials. , 2003 .
[78] Valeria Souza,et al. Stress-Induced Mutagenesis in Bacteria , 2003, Science.
[79] M. Rees,et al. Evolution of flowering strategies in Oenothera glazioviana: an integral projection model approach , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[80] D. O. Logofet. Matrix Population Models: Construction, Analysis, and Interpretation , 2002 .
[81] S. Rosenberg. Evolving responsively: adaptive mutation , 2001, Nature Reviews Genetics.
[82] C. Finch,et al. Relevance of 'adaptive' mutations arising in non-dividing cells of microorganisms to age-related changes in mutant phenotypes of neurons. , 1997, Trends in neurosciences.
[83] S. Lessard. Fisher's fundamental theorem of natural selection revisited. , 1997, Theoretical population biology.
[84] B. Hall,et al. Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[85] R. S. Harris,et al. Adaptive mutation by deletions in small mononucleotide repeats. , 1994, Science.
[86] M Slatkin,et al. Fisher's fundamental theorem of natural selection. , 1992, Trends in ecology & evolution.
[87] B. Strauss. The origin of point mutations in human tumor cells. , 1992, Cancer research.
[88] J. Overbaugh,et al. The origin of mutants , 1988, Nature.
[89] A. Edwards,et al. Fundamental Theorem of Natural Selection , 1967, Nature.
[90] J. Willis. The Origin of Species by Large, rather than by Gradual, Change, and by Guppy's Method of Differentiation , 1923 .
[91] A. Dhawan,et al. Mathematical modelling of plasticity and phenotype switching in cancer cell populations. , 2017, Mathematical biosciences.
[92] W. Witte,et al. Antibiotic resistance. , 2013, International journal of medical microbiology : IJMM.
[93] M. Hooten,et al. Climate influences the demography of three dominant sagebrush steppe plants. , 2011, Ecology.
[94] B. Frieden,et al. Adaptive therapy. , 2009, Cancer research.
[95] M. Gordon. Inhibition of Interleukin-6 with CNTO328, an Anti-Interleukin-6 Monoclonal Antibody, Inhibits Conversion of Androgen-Dependent Prostate Cancer to an Androgen-Independent Phenotype in Orchiectomized MiceWallner L, Dai J, Escara-Wilke J, et al (Univ of Michigan, Ann Arbor; Univ of Pittsburgh, Pa; Tian , 2007 .
[96] J. Shapiro. Observations on the formation of clones containing araB-lacZ cistron fusions , 2004, Molecular and General Genetics MGG.